Empowering The Athlete Within: Exercise Intelligence Partners with Supersapiens

Atlanta – 17 October 2023 /ENDURANCE SPORTSWIRE/ – Supersapiens, the world’s first glucose management system for athletes, is excited to announce its strategic partnership with Exercise Intelligence (EXI), an acclaimed health and exercise innovator. United in a shared vision, both entities aim to “awaken the athlete within everyone”, harnessing the power of state-of-the-art technology and holistic health expertise.

“The partnership with EXI marks an exciting chapter in our journey. As we continue to strive to help all athletes optimize performance, uniting with EXI helps amplify our mission, bringing insights to athletes everywhere,” remarked Phil Southerland, Supersapiens CEO and Founder. “Our collaboration signifies more than just a partnership; it’s a commitment to empower every individual to activate their true athletic potential.”

EXI’s mission is to help millions accelerate the achievement of their most challenging health goals by helping them elevate activity levels and activate their innate athleticism, regardless of their starting point. EXI recognizes that every person has a unique athlete within them, waiting to be unveiled; EXI’s approach integrates seamlessly with Supersapiens’ dedication to optimizing performance through scientific analytics and insights.

“Allying with Supersapiens aligns perfectly with our vision at EXI,” commented EXI CEO Grace McNamara. “Their groundbreaking ecosystem, combined with our personalized exercise program for health promises a transformative experience for all individuals on their journey to better health and fitness. We believe that together, we can redefine what it means to awaken the athlete within.”

Supersapiens is focused on using science with sport to help all athletes reach their highest potential. Their ecosystem, including the Supersapiens app, Supersapiens Energy Band, and Supersapiens Data Dashboard, integrates with a host of wearables and performance tools, including Apple Watch, select Wahoo and Garmin devices, TrainingPeaks, Nolio app, Apple Health, and more.

Powered by Abbott’s Libre Sense Glucose Sport Biosensor, Supersapiens is a pioneering solution that gives athletes a deeper understanding of the intricate relationship between glucose levels and energy. For more information on the extensive range of Supersapiens products and to purchase Abbott’s Libre Sense biosensor, visit www.supersapiens.com.

About Supersapiens

Supersapiens is aiming to be the most influential sports brand of the decade. They develop innovative insights around glucose that aim to unlock better performance and recovery by driving positive behavior changes. Abbott’s Libre Sense Glucose Sport Biosensor is intended for athletes to measure their glucose levels. When used with a compatible product, the biosensor allows athletes to correlate their glucose levels and their athletic performance. The Supersapiens system including Abbott’s Libre Sense Glucose Sport Biosensor is not intended for medical use and is not intended for use in screening, diagnosis, treatment, cure, mitigation, prevention, or monitoring of diseases, including diabetes.

About EXI

EXI is Exercise Intelligence – a Software as a Medical Device (SaMD), part of the emerging field of digital therapeutics, that supports professionals and employers to refer people to exercise appropriately, and people with long-term health conditions to safely increase their physical activity. It’s designed for up to 23 long-term physical and mental health conditions such as obesity, cardiovascular disease, diabetes, hypertension, stroke, asthma, COPD, depression, anxiety and stress. Fully regulated and bringing together behavior change science with the latest clinical evidence and physical activity guidelines, it delivers safe, scalable, measurable health interventions that are medically proven, achievable and simple to monitor. It also harnesses behavior change support and rewards to engage people in their program, drive adherence and support sustained physical activity. 

The initiative combines the use of the Apple Watch, EXI mobile app and a compelling rewards scheme. Together, these elements will motivate and engage diabetic patients in Milton Keynes over a 24-month period, encouraging positive lifestyle changes.

The EXI app will be used to prescribe personalised exercise programmes for each patient in the scheme. Drawing upon the latest research across a spectrum of long-term health conditions, including but not limited to diabetes, obesity, cardiovascular disease, anxiety, and depression. EXI ensures the safety and feasibility of exercise prescriptions.

For those with iPhones, an Apple Watch will be provided, offering a wealth of health sensors, unrivalled privacy and security features, an exceptional user experience, and consent controls centered on the user. This invaluable tool will enable patients to track their progress and adhere to their prescribed exercise routines.

To further incentivise and motivate participants, we are introducing a rewards system that will recognise and celebrate their achievements in meeting their physical activity goals throughout the entire 24-month program.

Grace McNamara, CEO of EXI, emphasises the significance of this initiative, stating, “We firmly believe that interventions like this are pivotal in improving the well-being of patients with diabetes while alleviating the strain on primary care, both in terms of GP resources and the NHS budget.”

Louise O’Mahony, Head of Customer Success at EXI advocates, “By harnessing the power of technology, we can deliver personalised care that empowers patients to actively participate in their health journeys, fostering long-term, sustainable behaviour change. In doing so, we can redirect valuable time back to our clinical staff and contribute to reducing the overall costs associated with diabetes treatment—a condition currently costing the NHS around £10 billion annually, projected to increase to £16.9 billion by 2035, representing 17% of its annual budget.”

Moreover, the Centre for Lifestyle Medicine and Behaviour at Loughborough University and the hospital Research & Development department will jointly lead an independent evaluation to gauge the program’s effectiveness in achieving its objectives, which include promoting lasting behaviour change, enhancing diabetes management, and reducing NHS costs. This comprehensive research endeavour will encompass both quantitative and qualitative data collection and analysis, with findings anticipated in 2025.

EXI remains steadfast in its commitment to revolutionising diabetes care and looks forward to working closely with the Milton Keynes Health and Care Partnership and the broader healthcare community to empower individuals living with diabetes in Milton Keynes and beyond. 

Partnership aims to provide support for people living with chronic conditions via personalised exercise prescriptions. 

London. September 4, 2023 – EXI, the Software as a Medical Device (SaMD) that personalises physical activity for people with long-term health conditions, today announced a partnership with NHS Mid and South Essex University Hospitals Group, marking a significant leap forward in healthcare innovation.

“Our team are thrilled to announce our partnership with NHS Mid and South Essex University Hospitals Group. This exciting collaboration reinforces our shared commitment to delivering exceptional healthcare solutions to the NHS and its valued patients”, said Louise O’Mahony – Head of Healthcare Partnerships at EXI.

At the heart of this partnership is an innovative initiative to redefine cardiac rehabilitation services across three leading hospitals. Leveraging state-of-the-art technology and compassionate care, EXI and NHS Mid and South Essex Trust are set to transform the landscape of patient recovery.

Key Features of the Partnership:

Cutting-Edge Cardiac Rehab Services: Through this collaboration, patients will experience a seamless blend of on-site and remote cardiac rehab services, powered by the EXI platform. This innovative approach ensures that patients receive gold standard care, irrespective of their location.

Empowering Patient Journey: The partnership aims to empower 3,000 patients with a Fitbit, that will play a pivotal role in their rehabilitation journey. This technology-driven empowerment will drive progress and enhance overall well-being.

Guided by Expert Health Coaches: As part of the initiative, an in-house health coach will be introduced, driving digital transformation within the cardiac clinical team. This strategic addition underscores the commitment to holistic care and patient-centered rehabilitation.

Optimized Patient Experience: From seamless onboarding to ongoing support, the partnership is dedicated to optimising every aspect of the patient journey. The focus is on providing an unparalleled experience that sets new standards in healthcare excellence.

The partnership signifies a united effort to shape a healthier future for the UK’s healthcare landscape. Stay tuned for inspiring patient stories that will showcase the impact of this partnership, as individuals embrace their cardiac rehab journey from a hospital setting to the comfort of their home and communities.

About EXI

EXI is Exercise Intelligence – a Software as a Medical Device (SaMD), part of the emerging field of digital therapeutics, that supports professionals to prescribe and refer patients to exercise appropriately, and people with long-term health conditions to safely increase their physical activity. It’s designed for up to 23 co-morbid physical and mental health conditions, including prevalent and serious non-communicable diseases (NCDs) such as obesity, cardiovascular disease, diabetes, hypertension, stroke, asthma, COPD, depression, anxiety, and stress. Fully regulated and bringing together behaviour change science with the latest clinical evidence and physical activity guidelines, it delivers safe, scalable, measurable health interventions that are medically proven, achievable for the end user, and quick and simple to prescribe and monitor. It also harnesses behaviour change support and rewards to engage patients in their prescription, drive adherence and support sustained physical activity. A smartphone app supports end users while a secure data portal allows the professional to monitor outcomes and adherence.

Partnership aims to provide support for people living with chronic conditions via personalized exercise prescriptions. 

Irvine, CA. August 16, 2023 – EXI, the Software as a Medical Device (SaMD) that personalizes physical activity for people with long-term health conditions, today announced a first-of-its-kind partnership with Hyperice, a global high-performance wellness brand that specializes in technology that promotes the recovery, mobility and improved movement of muscles and joints.

Through this partnership, Hyperice’s Normatec dynamic air compression system will be offered through the EXI platform, providing pain relief for its users living with diabetes as a particular focus and multiple long-term health conditions. Normatec by Hyperice has been well-established in elite sports, where its technology is used effectively to enhance dynamic warm-ups and recovery for professional athletes, and over recent years has expanded its reach to the general population as a viable solution for increasing circulation and decreasing inflammation in the lower body through its compression boots. 

“At present, if clinicians want to provide patients with devices for home monitoring – an ECG holter monitor, for example – it’s on a short-term loan basis and inhibits positive habit changes,” said Grace McNamara, CEO of EXI. “At EXI, we’ve identified a number of existing high-quality medical-grade consumer products that are backed by science and easy to use. By offering Normatec to our consumers, we can promote and support long-standing self-care at home utilizing technology that is backed by science.”  

EXI’s forward-thinking approach effectively combines person-centered consumer technology with healthcare delivered at home, and we’re excited to be part of it,” said Jim Huether, CEO of Hyperice. “The collaboration of technologies, specifically with our Normatec compression systems, represents a win-win for patients and clinicians, supporting improved outcomes for patients within a remotely monitored, self-care model.”

Normatec’s precision pulse technology has been shown in numerous peer-reviewed studies to offer benefits as diverse as increased range of motion^[1] and reduced pain sensitivity^[2]. Studies have shown that a single bout of Normatec Pulse compression improves conduit artery endothelial function systemically, as well as RH blood flow in the compressed limbs^[3], and that Normatec Pulse compression also significantly increases total and oxygenated haemoglobin^[4].

About EXI

EXI is Exercise Intelligence – a Software as a Medical Device (SaMD), part of the emerging field of digital therapeutics, that supports professionals to prescribe and refer patients to exercise appropriately, and people with long-term health conditions to safely increase their physical activity. It’s designed for up to 23 co-morbid physical and mental health conditions, including prevalent and serious non-communicable diseases (NCDs) such as obesity, cardiovascular disease, diabetes, hypertension, stroke, asthma, COPD, depression, anxiety and stress. Fully regulated and bringing together behavior change science with the latest clinical evidence and physical activity guidelines, it delivers safe, scalable, measurable health interventions that are medically proven, achievable for the end user, and quick and simple to prescribe and monitor. It also harnesses behavior change support and rewards to engage patients in their prescription, drive adherence and support sustained physical activity. A smartphone app supports end users while a secure data portal allows the professional to monitor outcomes and adherence. For more information, visit EXI.life. 

About Hyperice

Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), mind technology (Core by Hyperice) and contrast therapy (Hyperice X). Now, as a holistic high-performance wellness brand, Hyperice is designed for all – from the most elite athletes, leagues, and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance, and workplace wellness on a global scale. Hyperice’s transformative acquisitions of Normatec, RecoverX, and Core have helped to accelerate its innovation agenda as it enters its next stage of global growth. For more information, visit the newly redesigned hyperice.com.

^[1] Journal of Strength and Conditioning 2014

^[2] Journal of Strength and Conditioning 2015

^[3] European Journal of Applied Physiology 2015

^[4]Journal of Sport Rehabilitation 2018

Olivia Williams, an exercise specialist, and Dr. Anjali Zalin, a consultant obesity physician, describe why and how they integrated a digital solution into their services, and share some of the reasons they feel it has benefitted their patients. With over 400 patients already beginning a physical activity journey with EXI so far, their experiences provide a wealth of expertise and advice for anyone seeking to augment weight management services with EXI.

The #healthtech 50 focuses on companies creating tech for personal and preventative healthcare, as well as GP practice management and messaging platforms. 

Final rankings to determined the top 50 was a combination of a 1000 strong reader vote and choices from an independent judging panel featuring leaders at techUK, Ethical Healthcare Consulting, Doctorpreneurs & BusinessCloud. EXI placed at number 8, climbing 10 places from last years list.

The judging panel was comprised of:
• Dr Avi Mehra, co-founder and MD, Doctorpreneurs
• Leontina Postelnicu, head of health and social care, techUK
• Lauren Bevan, director of consulting, Ethical Healthcare Consulting
• Jonathan Symcox, editor, BusinessCloud

Discover the full list here:
https://lnkd.in/eDAZSpav

Weight-loss medications aren’t a ‘miracle fix’ says EXI CEO, Grace McNamara B.Sc. MPH. EMBA. in the Metro article regarding Rishi Sunak’s announcement of a new £40,000,000 pilot scheme that will give thousands of obesity patients access to the weight loss jab Wegovy, approved for use in May by the NICE – National Institute for Health and Care Excellence for use on the NHS.

Grace tells Josh Milton at metro UK, that “weight management is about combining them [weight-loss medications] with nutrition, exercise and behaviour support”.

Read the full article here:
https://lnkd.in/eV7wwyva

EXI’s head of research, Dr. Lou Atkinson features in the latest edition of HCM. She tells Kate Cracknell how EXI is connecting Physical Activity and Medicine.

Read the article here

©Cybertrek 2023 Issue 5 2023.